Fixed maturities available for sale, at fair value

Equity securities at fair value

Commercial mortgage loans on real estate, at amortized cost

Short-term investments

Other investments

Total investments

Total assets

Total liabilities

Total Assurant, Inc. stockholders equity

Non-controlling interest

Total equity

Total liabilities and equity

Revenues

Net earned premiums

Fees and other income

Net investment income

Net realized gains on investments

Total revenues

Benefits, losses and expenses

Policyholder benefits

Amortization of deferred acquisition costs and value of business acquired

Underwriting, general and administrative expenses

Interest expense

Total benefits, losses and expenses

Income before provision for income taxes

Provision for income taxes

Net income from continuing operations

Earnings Per Common Share

Net income from continuing operations - Basic

Net income from continuing operations - Diluted

Weighted average common shares outstanding - Basic

Weighted average common shares outstanding - Diluted

Revenues

Net earned premiums

Fees and other income

Net investment income

Net realized losses on investments

Amortization of deferred gain on disposal of businesses

Total revenues

Benefits, losses and expenses

Policyholder benefits

Amortization of deferred acquisition costs and value of business acquired

Underwriting, general and administrative expenses

Goodwill impairment

Iké net losses

Interest expense

Total benefits, losses and expenses

Income before provision for income taxes

Provision for income taxes

Net income from continuing operations

Earnings Per Common Share

Net income from continuing operations - Basic

Net income from continuing operations - Diluted

Weighted average common shares outstanding - Basic

Weighted average common shares outstanding - Diluted

Revenues

Net earned premiums

Fees and other income

Net investment income

Net realized gains on investments

Amortization of deferred gain on disposal of businesses

Total revenues

Benefits, losses and expenses

Policyholder benefits

Amortization of deferred acquisition costs and value of business acquired

Underwriting, general and administrative expenses

Iké net losses

Interest expense

Loss on extinguishment of debt

Total benefits, losses and expenses

Income before provision for income taxes

Provision for income taxes

Net income from continuing operations

Earnings Per Common Share

Net income from continuing operations - Basic

Net income from continuing operations - Diluted

Weighted average common shares outstanding - Basic

Weighted average common shares outstanding - Diluted

Revenues

Net earned premiums

Fees and other income

Net investment income

Net realized losses on investments

Amortization of deferred gain on disposal of businesses

Total revenues

Benefits, losses and expenses

Policyholder benefits

Amortization of deferred acquisition costs and value of business acquired

Underwriting, general and administrative expenses

Interest expense

Total benefits, losses and expenses

Income before provision for income taxes

Provision for income taxes

Net income from continuing operations

Earnings Per Common Share

Net income from continuing operations - Basic

Net income from continuing operations - Diluted

Weighted average common shares outstanding - Basic

Weighted average common shares outstanding - Diluted

Reflects the disposition of assets and liabilities of the disposed Global Preneed business as if the Sale occurred on June 30, 2021.

Reflects the aggregate purchase price at the closing of the Sale (the “Closing”) of approximately $1.35 billion in cash, which was comprised of a base purchase price of $1.25 billion, adjusted for (i) the amount of Leakage (as defined in the Equity Purchase Agreement, dated as of March 8, 2021, by and among the Company, Interfinancial Inc., CMFG Life Insurance Company and TruStage Global Holdings, ULC (the “Equity Purchase Agreement”)) paid by the disposed Global Preneed business after December 31, 2020 and at or prior to the Closing, (ii) the amount of any Transaction Related Expenses (as defined in the Equity Purchase Agreement) paid by the disposed Global Preneed business after the Closing, (iii) the difference between the book value of certain assets in the disposed Global Preneed business’s investment portfolio as of December 31, 2020 and the value of cash paid in substitution for the fair market value of such assets and (iv) the accrual of interest on the base purchase price, as adjusted pursuant to clauses (i) to (iii), at a rate of 6% per annum during the period beginning on January 1, 2021 and ending on the date immediately prior to the date of the Closing. The purchase price is subject to a post-closing true-up mechanism as set forth in the Equity Purchase Agreement, which is expected to be determined within approximately 120 days from the date of the Closing. The net cash proceeds are net of $40.4 million of transaction costs associated with the Sale.

Reflects the estimated net income tax impact related to the estimated gain on the sale, excluding the portion of the gain that was recognized from accumulated other comprehensive income. The $30.6 million amount includes an income tax payable of $62.3 million, partially offset by a realization of deferred taxes of $31.7 million.

Reflects the estimated net gain on the Sale, including $112.5 million representing the net cash proceeds less the net assets of the disposed Global Preneed business and the recognition of $614.3 million from accumulated other comprehensive income as summarized in footnote (e) below. An estimated gain/loss is not included in the adjustments in the unaudited pro forma consolidated statements of operations as this amount will be included in discontinued operations in the consolidated statements of operations of the Company beginning in the third quarter of 2021.

Reflects the recognition of $614.3 million from accumulated other comprehensive income in retained earnings, comprised of $782.2 million of net unrealized gains on investments and $2.0 million of foreign currency translation adjustments. These adjustments are subject to $169.9 million of income tax expense.

Reflects the elimination of the results of the disposed Global Preneed business as if the Sale occurred on January 1, 2018.

Reflects the fee income earned and operating expense incurred in connection with the transition service agreement (“TSA”) between the Company and CUNA, which will expire two years after the Sale. As this adjustment relates to a new contractual arrangement, the effects are limited in the unaudited pro forma condensed consolidated statements of operations to the most recent full year and interim period presented.

Reflects an adjustment for the estimated income tax effect of the pro forma adjustments. The estimated tax effect on the pro forma adjustments was calculated using the historical statutory rate in effect for the period presented.